IMAGE: The Centre for Genomic Regulation (CRG) and la Caixa Banking Foundation hosted a gathering of scientists, doctors, patients’ associations and biomedical companies to discuss the importance of integrating genomic data… view more
Credit: Peter Artymiuk, Wellcome Trust Images
Barcelona, April 13, 2018 – Àngel Font; corporate director for the area of research and strategy of the “la Caixa” Banking Foundation; Luis Serrano, director of the Centre for Genomic Regulation (CRG) and Arcadi Navarro, secretary of Universities and Research of the Autonomous Government of Catalonia, presented the main themes to be discussed by health experts at the seminar “The Impact of Genomic Data on Health: the Role of the European Genome-Phenome Archive (EGA)” in CosmoCaixa.
Seventeen years after determining the sequence of the human genome, genomic research and the technology that makes it possible have advanced at a remarkable pace. Today, genomic data have great potential to transform the practice of medicine, and are already having an impact in fields such as the diagnosis and treatment of rare diseases, cancer and other pathologies.
The use of genomic data in biomedical research has made it possible to advance in the knowledge of biologic processes and of a number of diseases. But the leap from research
Article originally posted at